4
Changes in Ownership
Lycia Therapeutics, Inc. Filed Acc 0001182471-26-000007
Options or other derivatives
- Director acquired 44,840 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| RIEFLIN WILLIAM JL Director | 2026-08-11 | Grant or award · Stock Option (Right to Buy) | +24,840 | 24,840 | D | ||
| RIEFLIN WILLIAM JL Director | 2026-10-22 | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | D | ||
Loading xslF345X06/form4-10262026_111031.xml…